COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Print ISSN:-2394-6369

Online ISSN:-2394-6377


Current Issue

Year 2020

Volume: 7 , Issue: 1

Article Access statistics

Viewed: 689

Emailed: 0

PDF Downloaded: 184

International Journal of Clinical Biochemistry and Research

Erythrocyte glutathione peroxidase levels in hyperthyroidism–effect of treatment with methimazole

Full Text PDF Share on Facebook Share on Twitter

Author Details : Sreekumari RG, Sandhya CV

Volume : 4, Issue : 1, Year : 2017

Article Page : 64-67

Suggest article by email


Background: The hypermetabolic state seen in hyperthyroidism causes increased oxygen consumption resulting in an increased formation of Reactive Oxygen Species leading to tissue injury. Increased oxidative stress characterised by elevated levels of free radicals and diminished antioxidant status has been described in animal models as well as in patients with hyperthyroidism. Thyroid gland is characterized by high activity of the antioxidant enzyme Glutathione Peroxidase (GSHPx) and this has been studied much reflecting the imbalance of antioxidant enzyme systems in thyroid dysfunction. However, contradictory results have been obtained regarding plasma and erythrocyte GSHPx levels in hyperthyroidism. Studies have also shown that antithyroid drugs like Methimazole and propyl thiouracil have antioxidant effects. How the treatment with these drugs affect the antioxidant status is also a matter of debate. Hence, the present study aimed to evaluate the erythrocyte Glutathione Peroxidase levels in hyperthyroidism in comparison with normal controls and evaluate the effect of methimazole treatment.
Methods: The study was carried out in patients attending the special investigation laboratory in the department of Biochemistry of our college for assessment of their thyroid function. The study groups included: Group 1 (n = 40) consisting of healthy euthyroid controls. Group 2: (n=30) clinically diagnosed hyperthyroid patients, 17 were untreated fresh cases (series1) and 13 patients were undergoing treatment with methimazole for the past one month (series2). Erythrocyte Glutathione peroxidase enzyme levels were analyzed in blood samples collected from these subjects along with thyroid function tests T3, T4 and TSH.
Results & Conclusion: Comparison of the mean values showed that the elevated levels of thyroid hormones have come down in the Methimazole (MMI) treatment group as expected. There were very low TSH levels in the untreated group whereas in treated group TSH levels were at the lower limit of normal range. The mean GSH Px levels in untreated hyperthyroid patients were significantly elevated (6.970± 0.302μmoles/L) compared to normal controls (6.117 ± 0.133μmoles/L). The GSHPx levels in the treated group were closer to the GSHPx values of the control group.(6.125 ± 0.482μmoles/L)

: Hyperthyroidism, Methimazole, Glutathione peroxidase, Oxidative stress, Antioxidant status, Reactive Oxygen Species

How to cite : Sreekumari Rg, Sandhya Cv, Erythrocyte glutathione peroxidase levels in hyperthyroidism–effect of treatment with methimazole. Int J Clin Biochem Res 2017;4(1):64-67

Copyright © 2017 by author(s) and Int J Clin Biochem Res. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (